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ABSTRACT
The nucleolar PeBoW-complex, consisting of Pes1,
Bop1 and WDR12, is essential for cell proliferation
and processing of ribosomal RNA in mammalian
cells. Here we have analysed the physical and
functional interactions of Pes1 deletion mutants
with the PeBoW-complex. Pes1 mutants M1 and M5,
with N- and C-terminal truncations, respectively,
displayed a dominant-negative phenotype. Both
mutants showed nucleolar localization, blocked
processing of the 36S/32S precursors to mature
28S rRNA, inhibited cell proliferation, and induced
high p53 levels in proliferating, but not in resting
cells. Mutant M1 and M5 proteins associated
with large pre-ribosomal complexes and co-
immunoprecipitated Bop1 and WDR12 proteins
indicating their proper incorporation into the
PeBoW-complex. We conclude that the dominant-
negative effect of the M1 and M5 mutants is
mediated by the impaired function of the PeBoW-
complex.
INTRODUCTION
Eukaryotic ribosome biogenesis is a highly regulated, evolu-
tionary conserved process in the nucleolus. A large precursor
ribosomal RNA (pre-rRNA) is transcribed by Pol I and rap-
idly packaged into the 90S ribonucleoprotein particle (90S
pre-RNPs) containing ribosomal proteins, non-ribosomal pro-
teins and snoRNA-containing ribonucleoprotein particles
(snoRNPs). The 90S pre-RNPs are processed into intermedi-
ates, which ﬁnally give rise to mature 40S and 60S ribosomal
subunits (1).
Ribosome biogenesis is the major metabolic challenge of
rapidly proliferating cells, particular in tumour cells, as it
consumes up to 80% of the total energy. However, little is
known about the molecular mechanism that ensure the equi-
librium between cell division and ribosome biogenesis
required for balanced cell proliferation (1). Recently it has
become evident that ribosome synthesis is cell cycle con-
trolled and sensitive to growth factor and nutrient signalling,
and likewise inhibited upon stress signals. Interestingly, sev-
eral pivotal regulators of cell cycle progression and senes-
cence, such as p19ARF reside within the nucleolus and are
also involved in the control of ribosome biogenesis. More-
over, nucleolar proteins like nucleophosmin not only function
in the maturation of ribosomes, but are also implicated in the
control of the tumour suppressors p53 and p19ARF (2,3).
Noteworthy, dysfunction of nucleophosmin is frequently
associated with acute myeloid leukaemia and heterozygous
mice develop myelodysplastic syndromes (4,5). In conclu-
sion, the recent years have unravelled remarkable links
between the nucleolus and cell cycle regulation, thus under-
lining the importance of the nucleolus far beyond the produc-
tion of ribosomes.
The nucleolus owns a particular ability in sensitizing cellu-
lar stress after ultraviolet (UV) radiation of cells. Using
micropore irradiation, Rubbi and Milner (6) demonstrated
that large amounts of nuclear DNA damage failed to stabilize
p53 unless the nucleolus was affected. In addition, forcing
nucleolar disruption by anti-upstream binding factor (UBF)
antibody microinjection (in the absence of DNA damage),
different chemotherapeutic drugs, or cre-mediated deletion
of the Pol I speciﬁc transcription factor TIF-IA also caused
p53 stabilization and a p53-dependent cell cycle arrest. This
suggests that the nucleolus is a stress sensor responsible for
the maintenance of low levels of p53, which are automatic-
ally elevated as soon as nucleolar function is impaired in
response to stress (6,7).
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cycle check points? Several mechanisms have been proposed
that link ribosome biogenesis to the cell cycle machinery in
mammalian cells. A central player in all models is Mdm2,
a p53-speciﬁc ubiquitin ligase. Disturbance of ribosome bio-
genesis may decrease the demand for ribosomal proteins and
thus lead to an excess of free ribosomal proteins as L5, L11
and L23, which directly bind and inactivate Mdm2 resulting
in the accumulation of p53 (8–12). Alternatively, export of
ribosomal subunits to the cytoplasm may be a critical step
for p53 degradation, which does not take place, if rRNA pro-
cessing is inhibited (13). However, other models cannot be
excluded.
We have recently described the nucleolar complex PeBoW,
consisting of Pes1 (Pescadillo), Bop1 (block of proliferation)
and WDR12 (WD-repeat protein) in mammalian cells.
Knockdown of WDR12 by siRNA technology or expression
of a dominant-negative WDR12 mutant blocked processing
of the 32S pre-rRNA, evoked stabilization of p53 and induced
a strong cell cycle arrest (14). Likewise, expression of
dominant-negative mutants of other members of the complex,
Pes1 and Bop1, inhibit rRNA processing and cell cycle pro-
gression (15,16).
The structure and function of the PeBoW-complex appears
to be highly conserved throughout evolution. A homolog
complex consisting of Nop7 (Yph1p), Erb1 and Ytm1p has
been identiﬁed in yeast. As in mammals, mutants of Nop7
and Ytm1 inhibit rRNA processing and cell cycle progression
(17). Mutations in Ytm1 disrupt interactions between Ytm1
and Erb1, destabilize the heterotrimer, and signiﬁcantly
reduce association of all three proteins with 66S pre-
ribosomes (18).
Even though a function of the PeBoW-complex in pro-
cessing of the 32S rRNA precursor is established, the struc-
ture of the complex and the role of its components Pes1,
Bop1 and WDR12 in other cellular processes is largely unre-
solved e.g. mouse embryos lacking Pes1 arrest at morula
stages of development, their nucleoli fail to differentiate
and accumulation of ribosomes is inhibited, suggesting an
essential role of Pes1 for ribosome biogenesis and nucleolo-
genesis (19). Overexpression of Pes1 can replace the SV40 T
antigen in inducing colony formation in soft agar growth but
not in inducing cell immortalization (20). Transient depletion
of Pes1 resulted in an increase of abnormal mitoses with
appearance of binucleate or hyperploid cells, of cells with
multipolar spindles and of aberrant metaphase plates (21).
Thus, Pes1 appears to be involved in multiple cellular pro-
cesses, yet it is unclear, whether all these processes require
the PeBoW-complex.
Recently, the interaction of Pes1 transposon insertion
mutants with Bop1 protein has been studied. Several of the
mutants displayed a dominant-negative phenotype for rRNA
processing. Interestingly, the dominant-negative phenotype
required the interaction of the mutant Pes1 with Bop1,
while Pes1 mutants, which did not interact with Bop1, failed
to induce a dominant-negative phenotype (15), suggesting
that Pes1 mutants might act only in the context of the
PeBoW-complex.
Here we report the generation of a set of Pes1 deletion
mutants and their interaction with the PeBoW-complex.
Two mutants with a N- and C-terminal deletion displayed a
dominant-negative effect on rRNA processing and cell
growth. Both mutants were incorporated into the PeBoW-
complex and induced accumulation of p53. Our data suggests
that essential cellular functions of Pes1 are mediated by its
incorporation into the PeBoW-complex.
MATERIALS AND METHODS
Cloning/plasmids
Pes1 was cloned from human cDNA using the following pri-
mers: HsPescadillo fwd: 50-GCCACCATGGGAGGCCTT-
GAGAAGAAG-30; HsPescadillo bwd: 50-CTCCGGCCTTG-
CCTTCTTGGCCTTC-30. Cloning into the modiﬁed pUC18
vector resulted in the addition of a C-terminal HA-tag to the
Pes1 open reading frame. The mutant Pes1-HA alleles were
created by standard techniques of molecular biology using
restriction enzymes and site directed mutagenesis. Pes1-HA
wild-type and mutants were cloned into the vector pRTS-1
using the SﬁI restriction site (22).
Tissue culture
TGR-1 rat ﬁbroblasts (provided by J. Sedivy, Brown Univer-
sity, Providence, RI) and U2OS osteosarcoma cells were cul-
tured in DMEM with 10% FBS at 8% CO2. For generation
of polyclonal cell lines, 6 · 10
5 cells were transfected with
7.5 mg pRTS-1 plasmids using Polyfect (QIAGEN) and selec-
ted in the presence of 200 mg/ml hygromycin B for 10 to
14 days. Conditional gene expression was induced with 1
mg/ml doxycycline. The percentage of induced cells was
monitored by FACS analysis for EGFP expression.
BrdU light assay
BrdU light assays were performed essentially as described
previously (23). Brieﬂy, stable polylclonal TGR-1 cells
were seeded in the presence of 1 mg/ml doxycycline at a dens-
ity of 10
5 cells per 100 mm well. After 30 h seeding, the cells
were incubated with 100 mM BrdU and doxycycline for 72 h.
Culture medium was then removed and replaced by medium
containing doxycycline and Hoechst 33258 at 2 mg/ml for
3 h. Finally, cells were placed on sheet of glass 11 cm
above a 30 W ﬂuorescent daylight bulb and irradiated from
beneath for 15 min. Cells were washed in phosphate-buffered
saline (PBS) two times and regular culture medium without
doxycycline was added.
RNA analysis and
32P in vivo labelling
Total RNA was isolated from TGR-1 cells using Trifast (Peq-
Lab). A total of 2 mg of RNA were separated on a 1%
agarose-formaldehyde gel and blotted on Hybond N
+ mem-
branes (GE Healthcare). The following
32P-labelled oligonuc-
leotides were used to visualize rRNA precursors: ITS-1, 50-
CCGGAGAGATCACGTACCACCCCCGGTGCACACGA-
GATCACGGAGCCG-30;I T S - 2 ,5 0-GGAGCGGTCGGCCC-
CGGTAGAGGGAGCGGGGGAGGAGAGGGACGCGAG-
30; 18S, 50-CACCCGTGGTCACCATGGTAGGCACGGCG-
ACTACCATCGAAAGTTGATAG-30.
For metabolic labelling of rRNA, TGR-1 cells were
induced with doxycycline for 24 h, followed by pre-
incubation in phosphate-free DMEM (Gibco) with dialyzed
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phosphate-free DMEM/10% dialyzed FBS containing 15 mCi/
ml
32P-orthophosphate (Amersham). After 60 min the radio-
active medium was removed and cells were incubated in
regular DMEM/10% FBS for indicated times. A total of
2 mg of RNA were separated on 1% agarose-formaldehyde
gels. After electrophoresis, gels were placed on whatman-
paper and dried at 80 C under vacuum suction. Dried agarose
gels were exposed to regular X-ray ﬁlms (Kodak) and rRNA
was visualized by autoradiography. A PhosphoImager (Fuji)
was used for the quantiﬁcation of signal intensities.
Sucrose gradients
Sucrose solutions were prepared in 50 mM Tris–HCl
(pH 8.0), 20 mM NaCl. Sucrose gradients from 50–5%
were prepared on top of a 300 ml CsCl (1.4 g/ml) cushion.
A total of 1 · 10
7 cells, without pre-treatment with cyclohex-
emide, were lysed in 1 ml lysis buffer [10 mM HEPES
(pH 7.9), 10 mM KCl, 1.5 mM MgCl2, 0.5 mM DTT, 0.1%
NP-40, protease inhibitors] at 4 C for 5 min. A total of 20 mg
of glass beads were added each and total cell lysates were
soniﬁcated 10 times for 1 s. A total of 100 ml of total cell lys-
ate were loaded on top of the sucrose gradients. Sub-
sequently, sucrose gradients were centrifuged at 30000
r.p.m. for 2.5 h using a Ti60W rotor. Fractions of 200 ml
each were collected. A total of 20 ml of each fraction were
used for SDS–PAGE electrophoresis.
siRNA transfection
The day before transfection, 5 · 10
4 to 10
5 U2OS cells were
seeded in 6-well plates. A total of 5 mlo f2 0mM control or
Pes1-speciﬁc siRNA were diluted in 150 ml Optimem (Invit-
rogen). A total of 150 ml Optimem containing 5 ml Oligo-
fectamine (Invitrogen) was added and incubated for 15 min.
Finally, 600 ml Optimem was added and applied to cells after
aspiration of the culture medium. Cells were incubated for
6 h. The following sequences (sense) were used: Pes1, CCA-
GAGGACCUAAGUGUGAdTdT; Control (nonspeciﬁc
siRNA), UUCUCCGAACGUGUCACGUdTdT.
Immunoblotting and immunofluorescence
Cells were directly lysed with 2· SDS-loading buffer (100 mM
Tris–HCl, 200 mM DTE, 4% SDS, 10 mM EDTA, 0.2%
bromphenol blue, 20% glycerol). Cell lysates were separated
by SDS–PAGE and blotted on nitrocellulose membranes (GE
Healthcare). Equal loading of samples was controlled by Pon-
ceau S staining. Immunodetection was performed with anti-
HA (3F10; Roche), anti-WDR12 (1B8), anti-Bop1 (6H11),
anti-Pes1 (8E9) [Holzel et al. (14)], and anti-p53 (Pab-240;
Dianova) antibodies.
For immunoﬂuorescence, cells were grown on cover slides,
ﬁxed with ice cold methanol or methanol–aceton 1:1 and air
dried. Unspeciﬁc binding was blocked with PBS/10% FBS.
p53 and HA-tagged Pes1 were detected with a 1:100 dilution
of anti-p53 antibody (Pab122; Dianova) and a 1:1000 dilution
of 3F10 anti-HA antibody, respectively. Primary antibodies
were incubated overnight at 4 C in a humidiﬁed chamber.
Cy3 labelled secondary antibodies (Dianova) were incubated
for 1 h at RT. Nuclei were counterstained with DAPI (Sigma–
Aldrich). Digital images were acquired using the Openlab
acquisition software (Improvision) and a microscope (model
Axiovert 200 M; Carl Zeiss MicroImaging, Inc.) with
63 (1.15) and 100 (1.30) plan oil objectives connected to a
ﬁve charge-coupled device camera (model ORCA- 479;
Hamamatsu).
Immunoprecipitation
For immunoprecipitations, U2OS cells were seeded at sub-
conﬂuent density and treated with 1 mg/ml doxycycline for
20 h. Cells were harvested by trypsination and washing
three times with PBS. For lysis, cells were resuspended in
lysis buffer [50 mM Tris–HCl (pH 8.0), 1% NP-40, 150
mM NaCl, protease inhibitors, phosphatase inhibitors] and
incubated on ice for 20 min. After centrifugation, protein
G beads (incubated with antibodies for at least 1 h, washed
twice after incubation) were incubated with the lysate over
night at 4 C. The beads were washed three times with lysis
buffer (lacking phosphatase- and protease inhibitor) and
resuspended in SDS-loading buffer/lysis buffer 1:1 with the
volume equal to the volume of cell lysate used for the IP.
RESULTS
Cloning and conditional expression of human
Pes1 mutants
The Pes1 protein is highly conserved in eukaryotes and sev-
eral domains and motifs have been predicted based on
sequence analysis (Figure 1A). Pes1 contains an evolutionary
highly conserved N-terminal pescadillo-like protein domain
(NPLP-domain, Pfam-database PF06732) at the N-terminus,
a BRCT domain located in the middle of the protein, three
classical nuclear localization sequences (NLS) distributed
over the protein, six bipartite NLS at the C-terminus and
two stretches of acidic amino acids near the C-terminus
(24). Pes1 is modiﬁed by SUMOylation, but SUMOylation
at the consensus site, yKXE, located at the C-terminus has
yet not been experimentally conﬁrmed (25). Human and
mouse Pes1 proteins are 89% identical (Figure 1A).
Systematic deletions are an appropriate tool for the invest-
igation of domains involved in subcelluar localization and
interactions as well as the generation of dominant-negative
mutants. A panel of pes1 deletion mutants covering the entire
open reading frame and a point mutation of the lysine in the
consensus SUMOylation site were constructed and tagged
with the hemagglutinin (HA) epitope at the C-terminus
(Figure 1A). For the conditional expression in mammalian
cells, wild-type (wt) and mutant pes1 alleles were cloned
into the pRTS-1 vector (Figure 1B) (14,22).
The expression of the gene of interest is tightly controlled
by a doxycycline-regulable trans-activator and trans-
repressor. Thus, this tight control prevents any selection
against vectors carrying dominant-negative pes1 alleles dur-
ing normal tissue culture due to leakiness of the promoter.
Moreover, the pRTS-1 vector allows for high expression
levels of the gene of interest. In stably transfected polyclonal
cell cultures, conditional gene activation is achieved in >95%
of cells (Figure 1C). As the bidirectional promoter of the
pRTS-1 vector accomplishes simultaneous expression of
EGFP in addition to the gene of interest, conditional gene
3032 Nucleic Acids Research, 2006, Vol. 34, No. 10Figure 1. Pes1 mutagenesis and conditional Pes1 expression. (A) A panel of Pes1 deletion mutants (M1–M8) were constructed. Recombinant Pes1 wt and mutant
proteins carry a C-terminal HA-tag. NLS: classical nuclear localization sequence; the N-terminal NLS consists of three overlapping NLS; bip. NLS: six
overlapping bipartite NLS; BRCT: BRCT domain; acidic domains: two glutamic acid rich regions; YKXE: consensus SUMOylation site; HA: hemagglutinin-
tag. Mutant M8 has replaced Lys517 by Arg. (B) Pes1 and its mutants were expressed in rat fibroblasts (TGR-1) stably transfected with the inducible EBV-based
vector pRTS-1. pRTS features a bidirectional promoter expressing simultaneously the gene of interest and EGFP. After induction by doxycycline, the vector
switches from active silencing to transactivation. (C) EGFP expression was induced in >95% of cells 24 h after addition of doxycycline, as determined by FACS
analysis. (D) Western blot analysis of wt or mutant Pes1 proteins in TGR-1 fibroblasts by anti-HA antibodies (3F10). The mock cell line expresses luciferase
instead of Pes1-HA. The indicated cell lines were treated with 1 mg/ml doxycycline for 30 h (+) or left untreated ( ). Bottom panel shows Ponceau S staining as a
loading control.
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escence microscopy (Figure 1B and C). Pes wt and mutants
M1–M8 were conditionally expressed in the rat ﬁbroblast
cell line TGR-1. Expression levels were determined 30 h
after addition of doxycycline by western blot analysis. Most
of the mutant forms were detected at the expected size, how-
ever deletion of the acidic regions in M5 and M6 signiﬁcantly
enhanced migration (Figure 1D).
Subcellular localization of Pes1 mutants
Pes1 protein has been reported to localize predominantly to
the nucleolus. To determine the subcellular localization of
the Pes1 mutants, we performed indirect immunoﬂuorescence
using HA-tag speciﬁc antibodies. As expected, the recombin-
ant Pes1 wt protein showed predominantly nucleolar
localization and also some nucleoplasmic staining in cells
with high expression of Pes1 (Figure 2, wt). The deletion of
54 N-terminal amino acids in mutant M1 did not affect the
nucleolar localization whereas the extension of this deletion
to amino acid 154 (M2) or 249 (M3) results in a diffuse nuc-
lear staining. Deletion of the central part of Pes1 containing
the BRCT domain and adjacent uncharacterized regions in
mutant M4 leads to a diffuse nucleoplasmic staining but
with nucleolar staining in very few cells (Figure 2, data not
shown). The C-terminal deletion mutants M5 to M7, together
with mutant M8 harbouring a mutated consensus SUMOyla-
tion site, located to the nucleolus as Pes1. Therefore, our
mutational analysis suggests that the region between 55 and
154 amino acid plays an important role for the nucleolar loc-
alization of the Pes1 protein. A contribution of the region
extending from amino acid 155 to 249 remains elusive for
Figure 2. Cellular localization of wt and mutant Pes1 proteins by indirect immunofluorescence. TGR-1 cells transfected with the indicated constructs were fixed
with methanol/acetone after induction of the Pes1-HA alleles with doxycycline for 30 h. The HA-tagged proteins were stained by anti-HA antibodies (3F10), the
nuclei were counterstained with DAPI.
3034 Nucleic Acids Research, 2006, Vol. 34, No. 10nucleolar localization in this study. Noteworthy, none of the
mutants showed cytoplasmic staining suggesting that neither
of the deletions affected the nuclear transport of Pes1. Since
all mutants retained at least two putative NLS, the functional-
ity of a single NLS could not be addressed by this set of
mutants.
N-terminal (M1) and C-terminal (M5) truncation
mutants potently inhibit proliferation and trigger
a reversible cell cycle arrest
Next, we tested the effect of Pes1 deletion mutants on cell
proliferation. Equal numbers of cells were seeded and expres-
sion of wt Pes1, mutants M1 to M8 and luciferase (mock) was
induced by addition of doxycycline. Cell numbers were
determined after 6d (Figure 3A). Overexpression of Pes1 wt
reduced the cell count to 62% compared to mock cells. A
likewise decrease was observed for the mutants M6, M7
and M8, and to a higher extent for the mutants M2, M3
and M4. Expression of the mutants M1 and M5 resulted in
the strongest reduction, 10 and 22% of mock cell count,
respectively. FACS analysis revealed a signiﬁcant increase
of cells in the G0/G1 phase of the cell cycle 48 h after expres-
sion of mutants M1 and M5 (Table 1, Supplementary
Figure S1). Hence, the mutants M1 and M5 suppressed cell
proliferation in rat ﬁbroblasts most efﬁciently.
Further, we studied the ability of mutants M1 and M5 to
mediate a reversible cell cycle arrest in a BrdU/light assay.
In brief, dividing cells that incorporate BrdU into their
DNA become highly photosensitive if they are additionally
labelled with the Hoechst dye 33 258 and undergo apoptosis
upon irradiation with visible light. Cell cycle arrested cells
are protected from increased photosensitivity and survive
BrdU/light treatment. Thus, cells that were arrested by condi-
tional expression of an anti-proliferative Pes1 mutant, would
subsequently give rise to colonies after withdrawal of doxy-
cycline. Mock cells expressing luciferase showed only little
colony outgrowth and thus demonstrating the low background
of this assay. Expression of Pes1 wt did not increase the num-
ber of colonies in comparison to the mock situation. The Pes1
mutant M1 provoked a pronounced rescue effect and sub-
sequent colony outgrowth, consistent with a strong reversible
cell cycle inhibition. The effect of mutant M5 was less
intense but still signiﬁcant. Mutant M3 showed a colony num-
ber slightly over the background level, while all other Pes1
mutants remained at the background level. The reduced pro-
liferation rates of Pes1 wt (62% in the proliferation assay) and
mutants M2–M4 and M6–M8 is not accompanied by an
increased apoptosis rate (data not shown) or altered cell
cycle distribution (Table 1), thus the reason for the reduced
cell count remains currently unclear. Taken together, the
mutants M1 and M5 mediated a potent inhibitory effect on
cell proliferation and triggered a reversible G0/G1-speciﬁc
cell cycle arrest (Table 1).
The Pes1 mutants M1 and M5 inhibit
pre-rRNA processing
Pes1 is involved in ribosome biogenesis and therefore we
tested the ability of mutants M1 and M5 to inhibit maturation
of ribosomal RNA. A short overview of the major mam-
malian rRNA processing pathway is depicted in Figure 4A.
Figure 3. Pes1 mutants M1 and M5 inhibit cell proliferation and elicit
a reversible cell cycle arrest. (A) Equal numbers of TGR-1 cells stably
transfected with the indicated constructs were seeded in multiples in
the presence of 1 mg/ml doxycycline. Cells were trypsinized and
counted by trypan blue exclusion after 6d. The histogram depicts the
cell counts relative to the mock cell line after 6d. Error bars indicate SD.
(B) Reversible cell cycle arrest by overexpression of mutants M1 and M5.
Stably transfected TGR-1 cell lines were seeded at low density and
treated with 1 mg/ml doxycycline for 30 h to induce expression of
the specified constructs. Subsequently, the cells were incubated with
100 mM BrdU for 72 h to label proliferating cells. Visible light
irradiation in the presence of Hoechst 33258 selectively kills cells that
have incorporated BrdU in their DNA. Arrested cells survive BrdU light
treatment and give rise to colonies after withdrawal of doxycycline.
Images show representative BrdU light assays conducted with the indicated
cell lines.
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30 h. Total RNA was isolated, and analysed by northern ana-
lysis with hybridization probes speciﬁc for the internal
transcribed spacer 1 and 2 (ITS-1 and ITS-2) of the ribosomal
pre-RNA (Figure 4A). Expression of M1 and M5-induced a
signiﬁcant accumulation of the 36S precursor as visualized
by hybridization with the ITS-1 speciﬁc probes (Supplement-
ary Figure S2). Inhibition of pre-rRNA processing becomes
even more pronounced, if rRNAs were hybridized with the
ITS-2 speciﬁc probe. Mutants M1 and M5 lead to a strong
increase of the amount of 32S rRNA precursor (Figure 4B,
upper arrows). While both mutants, M1 and M5, induced
accumulation of the 36S/32S rRNA, their effect on pro-
cessing of the 12S rRNA intermediate differed. The level
of 12S pre-rRNA was reduced for the mutant M1, but
appeared unaffected for the mutant M5 (Figure 4B, lower
arrows). This may indicate separable and common functions
of the mutants M1 and M5 in rRNA processing.
In addition we studied the impact of mutants M1 and M5
on rRNA processing in TGR-1 cells by metabolic
32P-labelling (Figure 4C). The production of mature 28S
rRNA was severely reduced resulting from an inefﬁcient pro-
cessing of the 32S rRNA precursor, as concluded from the
relative high abundance of metabolically labelled 32S
rRNA (Figure 4D). In contrast, synthesis of mature 18S
rRNA was almost unaffected. These results are in line with
our northern blot analysis. In conclusion, the deletion of the
N-terminus or the C-terminus of Pes1 either compromises
ribosome biogenesis by blocking rRNA processing at the
level of the 32S rRNA precursor.
Endogenous Pes1 is required for rRNA processing
and cell proliferation
To conﬁrm the role of Pes1 in ribosome biogenesis and cell
proliferation, we performed small interfering RNA (siRNA)
knockdown experiments of endogenous Pes1. We used
human osteosarcoma U2OS cells, because we had generated
a monoclonal antibody directed against human Pes1 (14).
Cells were transfected at day 0, 1 and 2 with either control
or Pes1-speciﬁc siRNA. Expression of endogenous Pes1
was dramatically reduced, as monitored by western blot ana-
lysis 2d after the last transfection (Figure 5A). Moreover, pro-
liferation of Pes1-depleted cells was severely impaired (data
not shown). Further, we investigated the impact of Pes1
knockdown on ribosome biogenesis after in vivo labelling of
rRNA. The production of the mature 28S rRNA was strongly
compromised (Figure 5B). Notably, synthesis of the large
45/47S precursor was not affected, indicating that Pes1 is
not involved in rRNA transcription. In conclusion, expression
of dominant-negative Pes1 and depletion of endogenous Pes1
block rRNA processing of the 32S rRNA precursor.
Mutants M1 and M5 induce p53 accumulation
in proliferating, but not in starving cells
As mentioned before, p53 is believed to induce cell cycle
arrest following nucleolar stress. This raised the question if
the observed impact of mutants M1 and M5 on pre-rRNA
processing triggers the accumulation of p53. To address this
question, we analysed p53 levels in TGR-1 cells 30 h after
expression of wt and mutant Pes1 proteins by western blot-
ting (Figure 6A). Pes1 wt and mock cells did not accumulate
p53 (Figure 6A, lanes 1–4). Expression of mutant M1 pro-
voked a strong increase of p53 protein (lanes 5 and 6). A
less pronounced accumulation was seen for the mutants M3
and M5 (lanes 9, 10 and 13, 14), whereas all other mutants
caused no change in p53 levels. If disturbance in ribosome
biogenesis is the reason for p53 accumulation, then the accu-
mulation of p53 should be diminished in cells in the absence
of active ribosome biogenesis, such as serum-starved cells.
To test this assumption, subconﬂuent TGR-1 cells were cul-
tured with 0.1% FBS for 72 h prior to the addition of doxy-
cycline. The cells were lysed 30 h later. Serum starvation did
not affect the induction rate of recombinant proteins
(Figure 6B, lower panel, see also Figure 1D), however,
neither of the Pes1 mutants was able to trigger the accumula-
tion of p53 (Figure 6B, upper panel).
To further investigate the p53 accumulation induced by the
mutant Pes1 proteins on the single cell level, we analysed p53
accumulation by immunoﬂuorescence (Figure 6C). In prolif-
erating cells expressing Pes1 wt, 8.9% of nuclei stained pos-
itive for p53. Expression of Pes1 mutants M1 and M5
increased the number of positive cells to 82.0 and 53.4%,
respectively (Figure 6D). Serum starvation reduced the num-
ber of p53-positive cells for Pes1 wt to 0.71%, and for the
mutants M1 and M5 to 8.7 and 3.3%, respectively. Thus
neither of the mutants were able to induce p53 signiﬁcantly
in serum-starved cells supporting the notion, that ribosome
biogenesis is a prerequisite for the dominant-negative action
of Pes1 mutants M1 and M5.
As previously demonstrated, N-terminally deleted WDR12
elicited a p53-dependent cell cycle arrest that was attenuated
by the coexpression of the human papillomavirus protein E6
(14), a ubiquitin ligase targeting p53 for degradation. In line
with these studies, mutants M1 and M5-induced cell cycle
arrest was alleviated in TGR-1 cells stably transfected with
HA-tagged E6 (Supplementary Figure S3).
Mutants M1 and M5 associate with the large
pre-ribosomal subunit
TheassociationofPes1mutantswithpre-ribosomalcomplexes
was studied by sucrose gradient fractionation using TGR-1
total cell lysates (Figure 7). All recombinant proteins accumu-
latedinlowmolecularfractions,mostlikelyduetoanaccessof
overexpressed free protein in total cell lysates. However, Pes1,
Table 1. Cell cycle distribution of Pes1 mutants
Cell line G0/G1 %S %G 2 %
Mock 46.6 23.1 30.4
WT 47.7 24.6 27.7
M1 62.3 17.8 19.9
M2 43.7 26.5 29.9
M3 53.5 18.2 28.3
M4 47.6 21.7 30.7
M5 59.1 18.9 21.9
M6 48.6 24.8 26.6
M7 49.5 22.6 27.9
M8 46.7 24.8 28.5
Stably transfected TGR-1 cells were induced at subconfluent density for 48 h
with doxycycline and subjected to FACS analysis. The percentage of cells in
different cell cycle phases are indicated.
3036 Nucleic Acids Research, 2006, Vol. 34, No. 10andmutantsM1andM5,butnotthe mutant M3,exhibited spe-
ciﬁc enrichment in high molecular weight fractions that co-
fractionated with ribosomal particles. Given the fact that M1
and M5 impair rRNA processing at the level of the 32S pre-
rRNA and co-sediment in fractions similar to the 60S peak
(see 28S RNA), our data suggests that mutants M1 and M5
accumulate with the 66S pre-ribosomal large subunit.
Incorporation of mutant Pes1 proteins into
the PeBoW-complex
Previously we showed that Pes1 forms a stable complex with
two other nucleolar proteins, Bop1 and WDR12, respectively
(PeBoW-complex). Interestingly, several of the deletion
mutants generated in this study localized to the nucleolus
Figure 4. Dominant-negative Pes1 mutants inhibit pre-rRNA processing. (A) Schematic of eukaryotic pre-rRNA processing. The top diagram shows the primary
47S transcript at the correct scale and the position of the probes used in the northern blots. The lower diagram shows the processing of the pre-rRNA
schematically. The effects of M1 and M5 overexpression are indicated. (B) Northern blot for pre-rRNA probed with ITS-2. Total RNA was extracted from
subconfluent TGR-1 cells transfected with the indicated constructs after 30 h of induction. Hybridization with a probe against the 18S rRNA confirms equal
loading of the blot. (C) Expression of dominant-negative Pes1 mutants impairs formation of mature 28S rRNA. Asynchronously growing TGR-1 cells were
treated with doxycycline for 24 h. Cells were pulse labelled with
32P-orthophosphate for 1 h and chased in regular medium for 0.5 and 3 h. (D) Ratio of 32S/28S
rRNA at 3 h after metabolic labelling with
32P-orthophosphate as described in (C).
Nucleic Acids Research, 2006, Vol. 34, No. 10 3037with or without a dominant-negative phenotype. Thus we
asked, if these mutants are nucleolar upon incorporation
into the PeBoW-complex or if nucleolar localization is a fea-
ture of Pes1 independent of PeBoW-association. Further, it
was unclear if the Pes1 mutants interact with Bop1 or
WDR12 in conjunction or independently of each other. More-
over, analysing the incorporation of the dominant-negative
mutant proteins M1 and M5 into the PeBoW-complex
would help to unravel the mechanism of their inhibitory func-
tion. To address these issues, we performed a series of vice-
versa immunoprecipitation experiments. As our antibodies
against the PeBoW components WDR12 and Bop1 are
human speciﬁc, we performed the experiments in the
human osteosacroma cell line U2OS. This cell line also
allowed proper conditional expression of Pes1 mutants by
the pRTS-1 vector.
U2OS cells were plated at a subconﬂuent density and the
Pes1 constructs were induced for 20 h with doxycycline.
The immunoprecipitation experiments were carried out with
antibodies against the HA-tag, WDR12 and Bop1, as well
as an isotype control. Western blot analysis was then per-
formed with a HA-tag speciﬁc monoclonal antibody (3F10)
to detect the recombinant Pes1 protein and monoclonal anti-
bodies against WDR12 and Bop1 to detect the association of
the recombinant Pes1 protein with endogenous PeBoW mem-
bers. In the mock cell line, the lack of the HA-tag, WDR12
and Bop1 speciﬁc signals in the IP against the HA-tag
revealed no unspeciﬁc reactivity of the antibodies
(Figure 8A). The endogenous PeBoW-complex was precipit-
ated in IPs against WDR12 and Bop1, as expected
(Figure 8A, lanes 3 and 4). HA-tagged Pes1 wt protein
co-immunoprecipitated high amounts of WDR12 and Bop1
indicating a proper incorporation into the PeBoW-complex
(Figure 8B, lane 2). The IPs against WDR12 and Bop1
could co-precipitate only a small fraction of HA-tagged
Pes1 protein (Figure 8B, lanes 3 and 4). This might be due
to the fact that 20 h after addition of doxycycline not all
PeBoW-complexes have incorporated the HA-tagged Pes1
protein. Hence, the co-immunopreciptation of WDR12 and
Bop1 with the anti-HA antibody is the most reliable readout
for the incorporation of HA-tagged Pes1 proteins in the
BeBoW-complex.
The dominant-negative mutant M1 co-precipitated WDR12
and Bop1 proteins (Figure 8C, lane 2). Mutant M1 was also
detectable in IPs against WDR12 and Bop1. This demon-
strates that the Pes1 mutant M1 is efﬁciently incorporated
into the PeBoW-complex (Figure 8C, lane 3 and 4). The
mutant proteins M2 and M3 are not incorporated into
PeBoW. Both proteins did not co-precipitate WDR12 and
Bop1 (Figure 8D and E, lane 2) and could not be precipitated
in IPs against WDR12 and Bop1 (Figure 8D and E, lane 3 and
4). This ﬁnding is compatible with a previous report, that the
region in Pes1 needed for nucleolar localization is also
needed for binding of Bop1 (15). Pes1 mutant M4 is also
not incorporated into the PeBoW-complex according to the
failure to co-precipitate signiﬁcant amounts of WDR12 and
Bop1 (Figure 8F, lane 2). The dominant-negative mutant M5,
similar to Pes1 wt and mutant M1 protein, co-precipitates
WDR12 and Bop1 (Figure 8G, lane 2) and is co-precipitated
by WDR12 and Bop1 (Figure 8G, lane 3 and 4). Mutants M6,
M7 and M8 are all incorporated into the PeBoW-complex, as
they co-precipitate WDR12 and Bop1 (Figure 8H–J, lane 2)
and in reciprocal IPs (Figure 8H–J, lanes 3 and 4). Taken
together, our immunoprecipitation studies revealed that all
mutants are efﬁciently incorporated in the PeBoW-complex
except the mutants M2, M3 and M4. Notably, the mutants
M2, M3 and M4 are the only mutants showing no proper nuc-
leolar localization, suggesting that the nucleolar localization
of Pes1 is linked to the PeBoW-association. Interestingly,
we observed no independent interaction of Pes1 mutants
with either Bop1 or WDR12. Further, our results propose
that dominant-negative forms of Pes1 require incorporation
into the PeBoW-complex for their negative effect on
ribosomal rRNA processing and cell cycle progression.
DISCUSSION
In mammals, Pes1, Bop1 and WDR12 proteins are compon-
ents of the evolutionary highly conserved PeBoW-complex,
which is required for maturation of the 60S ribosomal subunit.
Although PeBoW is highly abundant in the nucleolus, the way
and the place of its assembly is unclear. A homologous com-
plex in yeast, composed of Nop7, Erb1 and Ytm1, associates
with four consecutive 66S pre-ribosomal subunits containing
the 27SA2, 27SA3, 27SB and the 25.5S plus 7S pre-rRNAs
(18,26). Similar as in mammals, the yeast complex is required
for proper processing of the 27S pre-rRNA to the mature
Figure 5. Endogenous Pes1 is required for rRNA processing. (A) U2OS cells
were transfected at day 0, 1 and 2 with either control or Pes1-specific siRNA.
Endogenous Pes1 levels were analysed by western blot analysis 2d after the
last transfection. Tubulin is shown as a loading control. (B) U2OS cells were
transfected only twice at day 0 and 1 and metabolically labelled with
32P-orthophosphate for 60 min at day 3. Subsequently, cells were incubated
for 3 h in regular culture medium. Labelled rRNAs are indicated.
3038 Nucleic Acids Research, 2006, Vol. 34, No. 1025S rRNA. Recent evidence suggests that the assembly of the
trimeric yeast complex occurs in the nucleolus, with assembly
of Nop7 and Erb1 into the pre-ribosomes prior to Ytm1 (18).
Whether Nop7 and Erb1 assemble before binding to 66S pre-
ribosomes is not known. A stable complex of Nop7 and Erb1
has not been demonstrated yet, neither in yeast, nor for the
homologues Pes1 and Bop1 in mammalian cells. This is
intriguing since the interaction of Pes1 and Bop1 can easily
be demonstrated in GST-pull-down and yeast two hybrid
experiments (15). This suggests that the interaction of endo-
genous Pes1 and Bop1 may be inhibited during their passage
to the nucleolus and occurs only after association with the
pre-ribosome and/or the assembly of WDR12 in the complex.
Nucleolar transport and assembly of Pes1 into
the PeBoW-complex
In this study we have constructed a set of deletion mutants to
characterize the domains of Pes1 required for the nucleolar
localization and assembly into the PeBoW-complex. The
Pes1 protein has an evolutionary highly conserved N-terminal
domain of pescadillo-like proteins of 250 amino acids
Figure 6. Dominant-negative Pes1 mutants induce p53 accumulation in proliferating cells but not in quiescent cells. (A) Western blot for endogenous p53 levels.
Stably transfected TGR-1 cells were induced at subconfluent density for 30 h with doxycycline. Cell lysates were prepared and analysed by immunoblotting for
p53 accumulation using anti-p53 antibodies (Pab-240). n.s.: non specific. (B) Upper panel: western blot as described in (A), but the cells had been serum-starved
for 72 h before induction. Lower panel: immunoblot against the HA-tag to confirm the expression of recombinant wt and mutant Pes1. (C) Analysis of the
endogenous p53 response to expression of Pes1 wt, and mutants M1 and M5 by indirect immunofluorescence. Asynchronously proliferating and serum-starved
(72 h) cells were treated with doxycycline for 24 h to induce the Pes1 constructs. Cells were fixed in methanol and stained against p53 with anti-p53 (Pab122).
Cell nuclei were counterstained with DAPI. Representative images are shown. (D) Percentage of p53-positive nuclei in TGR-1 cells upon induction of Pes1 wt,
and the dominant-negative mutants M1 and M5. Proliferating and serum-starved cells were analysed by immunofluorescence as described in (C). Numberso f
examined cells are indicated in brackets. Error bars indicate SD of the percentage of p53-positive nuclei cells.
Nucleic Acids Research, 2006, Vol. 34, No. 10 3039followed by a distal BRCT domain (27). While the NPLP-
domain is present in all eukaryotes, the BRCT domain is
missing in some simple organisms as Plasmodium fal-
ciparum. Three of our deletions mutants, M1, M2 and M3,
successively lacked parts of the NPLP-domain. The removal
of 54 N-terminal amino acids of Pes1 in mutant M1 resulted
in a strong dominant-negative phenotype. Sucrose gradient
centrifugation, co-immunoprecipitation experiments and nat-
ive gel-electrophoresis experiments (data not shown) revealed
proper incorporation of mutant M1 protein into the PeBoW-
complex. Hence, the N-terminal 54 amino acids of the NPLP-
domain are neither required for the assembly of the PeBoW-
complex nor for the transport of Pes1 to the nucleolus. It is
more likely that the N-terminal domain of Pes1 fulﬁls other
essential tasks after the assembly of the complex by recruit-
ment of further factors, or by catalysing speciﬁc steps in the
maturation of the 32S pre-rRNA precursor. However, an
enzymatic activity of the complex has not been demonstrated
yet, neither in mammals nor in yeast. The mutants M2 and
M3 lacked larger parts of the NPLP-domain. Proteins of
both mutants were still transported into the nucleus. A trans-
port into the nucleolus, however, was inhibited. This is in line
with the observation that mutant M2 and M3 proteins did not
co-immunoprecipitate Bop1 and WDR12, because the
assembly of the PeBoW-complex in the nucleolus could not
take place. The absence of a dominant-negative phenotype
of both mutants also supports the model that incorporation
of Pes1 mutants into the PeBoW-complex is a prerequisite
for a dominant-negative phenotype. The region deleted in
M2 and M3 has been reported to interact directly with
Bop1 (15). The interaction domain with Bop1 has been iden-
tiﬁed in murine Pes1 after transposon insertion mutagenesis
of 19 extra amino acids downstream of amino acid
198 (Pes1-tn2), amino acid 202 (Pes1-tn11) and amino acid
204 (Pes1-tn12) (Figure 9) in yeast two hybrid experiments
(15). The failure of mutants M2 and M3 proteins to immuno-
precipitate complexes containing Bop1 and WDR12 supports
this notion. Anyway, incorporation of both mutant proteins
into the PeBoW-complex cannot take place, since they do
not localize to the nucleolus. In conclusion, the NPLP-
domain is critical for nucleolar localization and assembly of
the PeBoW-complex.
The Pes1 mutant M4 harbours a deletion of the BRCT
(BRCA1 C-terminal) domain that was ﬁrst described as an
essential domain of the tumour suppressor function of the
BRCA1 protein. Similar repeat sequences have been identi-
ﬁed in many proteins that function in DNA damage, repair
and replication. Many BRCT-containing proteins have
phospho-peptide binding activity suggesting that BRCT
repeats might mediate phosphorylation-dependent protein–
protein interactions in processes that are central to cell
cycle checkpoint and DNA repair functions. It is tempting
to speculate that the BRCT domain in Pes1 might fulﬁl sim-
ilar tasks and links nucleolar processes to cell cycle control
and DNA synthesis. Interestingly, a temperature sensitive
mutant of yeast Nop7, a homologue of Pes1, can speciﬁcally
inhibit S phase entry in yeast cells (17). This points to addi-
tional cell cycle control mechanisms by Pes1, which may act
independently of ribosome biogenesis. The mutant M4 pro-
tein did not co-immunoprecipitate Bop1 and WDR12 from
cellular lysates. This lack of interaction suggests that the
NPLP-domain in Pes1 is not sufﬁcient for binding of Bop1
in the nucleoplasm, or that the interaction of nucleoplasmic
Pes1 and Bop1 is negatively controlled by a yet unknown
mechanism. Importantly, in addition to the Bop1 interacting
domain, the BRCT domain also plays an important role in
nucleolar localization.
The second mutant with a strong dominant-negative
phenotype on cell proliferation and rRNA processing was
M5. Similar to M1, mutant M5 protein localized to the
Figure 7. Dominant-negative mutants M1 and M5 associate with large pre-ribosomal particles. Western-blot analysis of sucrose gradient fractions of TGR-1 cells
expressing Pes1-HA, and Pes1-HA mutants M1, M3 and M5 with an HA-specific antibody. RNA of each fraction was analysed by northern analysis with 28S
rRNA specific probe (lower panel).
3040 Nucleic Acids Research, 2006, Vol. 34, No. 10nucleolus and co-immunoprecipitated Bop1 and WDR12.
However, we noticed a speciﬁc difference in the processing
of the 5.8S rRNA for mutants M1 and M5. While the amount
of 12S pre-rRNA was reduced for mutant M1, the levels of
12S pre-rRNA were unchanged for the mutant M5. This sug-
gests an inhibition of 12S pre-rRNA processing by mutant
M5 and an accumulation of this precursor, whereas 12S
pre-rRNA processing proceeds in the presence of mutant M1.
Figure 8. Incorporation of Pes1 mutants into the PeBoW-complex. U2OS cells stably transfected with the indicated constructs (A–J) were seeded at subconfluent
density and treated with doxycycline for 20 h. The lysates were subjected to immunoprecipitation with antibodies either against the HA-tag (3F10), WDR12
(1B8), Bop1 (6H11) or the isotype control coupled to protein G Sepharose beads. The amount of protein loaded in each lane resembles an equivalent amounto f
total lysate or 20% thereof for the input. * indicates cross-reactivity to Ig molecules.
Nucleic Acids Research, 2006, Vol. 34, No. 10 3041The data suggests that the PeBoW-complex is required for
consecutive rRNA processing steps during maturation of
the 60S ribosomal subunit and that mutant M5 can block
the processing of the 12S pre-rRNA in addition to the 32S
pre-rRNA. Accordingly, the C-terminal domain of Pes1 is
required for processing of the 32S and 12S pre-rRNA pre-
cursors, whereas the N-terminal domain appears to be dis-
pensable for processing of the latter.
Role of the PeBoW-complex in cell cycle control
The impaired function of the PeBoW-complex evokes a p53
response in proliferating but not in serum-starved cells. All
three components of the PeBoW-complex are encoded by
Myc target genes and usually are not expressed in quiescent
cells (14,28,29). This suggests that expression of dominant-
negative mutants of Pes1 (this paper), or WDR12 (14) may
be not sufﬁcient for the induction of p53, because they cannot
assemble into the PeBoW-complex and block its function.
However, a recent study showed that human WI-38 ﬁbroblasts
accumulated p53 under growth-restricting conditions, such as
serum starvation or conﬂuency (30).
Whether the PeBoW-complex is directly involved in the
degradation of p53 remains unclear. Since dominant-negative
Pes1 mutants act only in the presence of ongoing ribosome
biogenesis it is conceivable that signalling of p53 degradation
should be linked to this process. Two non-mutually exclusive
mechanisms have been proposed for p53 degradation: nucle-
olar sequestration of Mdm2, and the blockage of a postulated
nucleolar route of p53 export for cytoplasmic degradation
(13,31). The Mdm2 sequestration model is supported by the
recent ﬁnding that several ribosomal proteins, L5, L11 and
L23, can bind and inhibit the function of Mdm2. Inhibition
of ribosome biogenesis leads to accumulation of free L5,
L11 and L23 proteins, which bind to and inhibit Mdm2-
mediated p53 ubiquitination and degradation. Inhibiton of
Mdm2 restores p53-mediated transactivation, accumulation
of p21 protein levels, and induction of cell cycle arrest
(5–9,27). The second model postulates a nucleolar export
route for Mdm2–p53 complexes and subsequent cytoplasmic
degradation of p53, termed by Sherr and Weber (13) as
Mdm2–p53 complexes ‘riding the ribosome’. This model is
supported by the observation that p53 can be covalently
linked to 5.8S rRNA, and associates with a subset of
ribosomes (32–34). Further support comes from the ﬁnding
that inhibition of nuclear export leads to accumulation of
p53 in the nucleus. If p53 has to enter the nucleolus for the
second model, or is loaded on ribosomal subunits during
the passage through the nucleoplasm, is currently an open
question. Evidence for the presence of p53 in the nucleolus
has recently been shown following cell permeabilization,
where most soluble nucleoplasmic p53 was eliminated, but
nuclear-bound p53 remained readily detectable in the nucleoli
(6). Accumulation of nucleolar p53 has also been observed
Figure 9. Boundaries and domains important for Pes1 function and PeBoW formation. Pes1 deletions mutants of this work were compared with transposon
insertion mutants published by Lapik et al. (15). Deletion mutants conferring a dominant-negative phenotype or affecting formation of PeBoW are indicated.
3042 Nucleic Acids Research, 2006, Vol. 34, No. 10after inhibiton of the proteasome (35). Alternatively, p53
associate with large pre-ribosomal subunits, if they leave
the nucleolus. Comparable to processing of the 27S pre-
rRNA in yeast (25), processing of the 32S pre-rRNA in mam-
malian cells probably occurs at the transition of the large pre-
ribosomal subunit from the nucleolus to the nucleoplasm. At
this moment, the functionality of the PeBoW-complex is
required. Successful processing of the 32S rRNA would
cause the release of the PeBoW-complex and loading of
Mdm2 and p53. A non-functional PeBoW-complex would
inhibit processing of the 32S pre-RNA and thereby nuclear
export of p53/Mdm2.
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